KLK3 and cancer: Notably, the prediction of disease outcome based on PSA levels alone is highly uncertain [24,25] and the value of PSA screening is almost obsolete for rapidly progressing cancers, which are in a pre-clinical state for a much shorter period of time, and are usually undetectable at an early stage [25].